| Linifanib; ABT-869 (CAS:796967-16-3, 1145655-58-8 (HCl), 796967-17-4 (TFA)) |
 |
|
|
Product No.
|
|
TP1060A
|
|
Name
|
|
Linifanib
|
|
Synonyms
|
|
ABT-869
|
|
CAS Number
|
|
796967-16-3, 1145655-58-8 (HCl), 796967-17-4 (TFA)
|
|
Structure
|
|
|
|
Brief Description
|
|
Linifanib (ABT-869) is a novel, potent ATP-competitive RTK inhibitor for KDR, CSF-1R, Flt-1, Flt-3 and PDGFRβ with IC50 of 4 nM, 3 nM, 3 nM, 3 nM, and 66 nM respectively.
|
|
Purity
|
|
>99%
|
|
Package
|
|
5mg, 10mg, 20mg, 50mg
|
|
|
|
|
|
